Response to Commentary by W. Jost on: Pharmaceutical, Biological, and Clinical Properties of Botulinum Neurotoxin Type A Products
Crossref DOI link: https://doi.org/10.1007/s40268-015-0091-y
Published Online: 2015-04-08
Published Print: 2015-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Frevert, Jürgen
License valid from 2015-04-08